Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Inna E. Tchivileva"'
Autor:
Inna E. Tchivileva, Richard Ohrbach, Roger B. Fillingim, Feng-Chang Lin, Pei Feng Lim, Samuel J. Arbes, Gary D. Slade
Publikováno v:
The Journal of Headache and Pain, Vol 22, Iss 1, Pp 1-11 (2021)
Abstract Background Headache attributed to Temporomandibular Disorder (HATMD) is a secondary headache that may have features resulting in diagnostic overlap with primary headaches, namely, tension-type (TTH) or migraine. This cross-sectional study of
Externí odkaz:
https://doaj.org/article/b305a41cac9045f3b148ad3ba60524a0
Publikováno v:
Journal of Oral Rehabilitation.
Autor:
Abbie Suttle, Peng Wang, Fabiana C. Dias, Qiaojuan Zhang, Yuhui Luo, Lauren Simmons, Andrey Bortsov, Inna E. Tchivileva, Andrea G. Nackley, Yong Chen
Publikováno v:
The journal of pain.
Temporomandibular disorder (TMD) pain that involves inflammation and injury in the temporomandibular joint (TMJ) and/or masticatory muscle is the most common form of orofacial pain. We recently found that transient receptor potential vanilloid-4 (TRP
Autor:
Shad B. Smith, Andrey V. Bortsov, Andrea G. Nackley, William Maixner, Roger B. Fillingim, Aurelio A. Alonso, Thomas Buchheit, Luda Diatchenko, William E. Whitehead, Joel D. Greenspan, Richard Ohrbach, Inna E. Tchivileva, Sheila M. Gaynor, Richard L. Boortz-Marx, Wolfgang Liedtke, Jongbae Park, Eric Bair
Publikováno v:
Pain
Traditional classification and prognostic approaches for chronic pain conditions focus primarily on anatomically based clinical characteristics not based on underlying biopsychosocial factors contributing to perception of clinical pain and future pai
Autor:
Samuel J. Arbes, Richard Ohrbach, Janet Willis, Roger B. Fillingim, Holly Hadgraft, Inna E. Tchivileva, Gary D. Slade
Publikováno v:
Journal of Dental Research
Propranolol is a nonselective β-adrenergic receptor antagonist that is efficacious in reducing facial pain. There is evidence that its analgesic efficacy might be modified by variants of the catechol-O-methyltransferase ( COMT) gene. We tested the h
Autor:
Shad B. Smith, Richard G. Boles, Vivek Verma, Marc Parisien, William Maixner, Gillian L. Drury, Andrea G. Nackley, Miranda A.L. van Tilburg, Anne-Julie Chabot-Doré, Denniz Zolnoun, William E. Whitehead, Samar Khoury, Luda Diatchenko, Inna E. Tchivileva, Gary D. Slade, Julian Smith-Voudouris
Publikováno v:
Pain
Alterations in cellular energy metabolism have been implicated in chronic pain, suggesting a role for mitochondrial DNA. Previous studies reported associations of a limited number of mitochondrial DNA polymorphisms with specific pain conditions. In t
Autor:
Richard Ohrbach, Massimiliano Di Giosia, Robert James, Gary D. Slade, Pei Feng Lim, Holly Hadgraft, Margarete C. Ribeiro-Dasilva, Janet Willis, Roger B. Fillingim, Samuel J. Arbes, John H. Campbell, Marcus Herman-Giddens, Inna E. Tchivileva
Publikováno v:
Pain. 161:1755-1767
Propranolol is a nonselective beta-adrenergic receptor antagonist. A multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 2b trial enrolled participants aged 18 to 65 years with temporomandibular disorder myalgia to evalua
Autor:
Roger B. Fillingim, Feng-Chang Lin, Samuel J. Arbes, Inna E. Tchivileva, Gary D. Slade, Pei Feng Lim, Richard Ohrbach
Publikováno v:
The Journal of Headache and Pain
The Journal of Headache and Pain, Vol 22, Iss 1, Pp 1-11 (2021)
The Journal of Headache and Pain, Vol 22, Iss 1, Pp 1-11 (2021)
BackgroundHeadache attributed to Temporomandibular Disorder (HATMD) is a secondary headache that may have features resulting in diagnostic overlap with primary headaches, namely, tension-type (TTH) or migraine. This cross-sectional study of people wi
Effect of comorbid migraine on propranolol efficacy for painful TMD in a randomized controlled trial
Autor:
Roger B. Fillingim, Janet Willis, Gary D. Slade, Massimiliano Di Giosia, Pei Feng Lim, Samuel J. Arbes, John H. Campbell, Margarete C. Ribeiro-Dasilva, Holly Hadgraft, Richard Ohrbach, Inna E. Tchivileva
Publikováno v:
Cephalalgia
Introduction The migraine-preventive drug propranolol is efficacious in reducing pain from temporomandibular disorder, suggesting potential modifying or mediating effects of comorbid migraine. Methods In this randomized controlled trial, myofascial t
Autor:
Pei F. Lim, Massimiliano Di Giosia, Gary D. Slade, Gary W. Jay, Inna E. Tchivileva, Daniela Vivaldi
Publikováno v:
Headache: The Journal of Head and Face Pain. 58:1593-1600
Headache attributed to temporomandibular disorders (TMDH) is defined as a secondary headache by the International Classification of Headache Disorders 3rd edition (ICHD-3). OBJECTIVE The objective of this case-control study is to investigate the phen